Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Hard to Swallow, Pharmacist-Led Strategies to Improve EoE Care

Access Activity

Overview / Abstract:

As the prevalence of eosinophilic esophagitis (EoE) continues to increase, pharmacists can play a pivotal role in its recognition, diagnosis, and recommendations for management. In this activity Dr. Gary Falk, a gastroenterologist, and pharmacists Dr. Brian Hemstreet and Dr. Hamai Tom discuss advances in EoE and the clinical implications of available and emerging therapies in long-term management.

To support application to practice a downloadable pharmacy toolkit is included, comprised of two infographics on diagnosis and therapy for EoE along with publicly available resources.

On May 20, 2022, the FDA approved dupilumab to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds).

Expiration

Apr 29, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Online

Credits / Hours

1.00 contact hour

Accreditation

ACPE

Presenters / Authors / Faculty

Gary W. Falk, MD, MS; Brian A. Hemstreet, PharmD, FCCP, BCPS; Erin Hamai Tom, PharmD, APh, MBA, BCACP

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Keywords / Search Terms

ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Tool Kit, Eosinophilic esophagitis, EoE, gastrointestinal, chronic disease, EoE chronic disease, EoE treatment, EoE accurate diagnosis, Gary W. Falk, MD, Brian A. Hemstreet, PharmD, Erin Hamai Tom, PharmD, budesonide, topical steroid, dupilumab, pharmacist, pharmacy, toolkit, downloadable resources Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map